PMC:7195088 / 26598-26803
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T130","span":{"begin":66,"end":74},"obj":"Disease"},{"id":"T131","span":{"begin":176,"end":184},"obj":"Disease"}],"attributes":[{"id":"A130","pred":"mondo_id","subj":"T130","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A131","pred":"mondo_id","subj":"T131","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Comparison of hydroxychloroquine vs. ascorbic acid in contacts of COVID-19 patients. Double-blind RCT (NCT04328961, not yet recruiting). Primary endpoint: laboratory-confirmed COVID-19 (follow-up 14 days)."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T354","span":{"begin":14,"end":32},"obj":"Chemical"},{"id":"T355","span":{"begin":37,"end":50},"obj":"Chemical"},{"id":"T357","span":{"begin":46,"end":50},"obj":"Chemical"}],"attributes":[{"id":"A354","pred":"chebi_id","subj":"T354","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"},{"id":"A355","pred":"chebi_id","subj":"T355","obj":"http://purl.obolibrary.org/obo/CHEBI_22652"},{"id":"A356","pred":"chebi_id","subj":"T355","obj":"http://purl.obolibrary.org/obo/CHEBI_29073"},{"id":"A357","pred":"chebi_id","subj":"T357","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"}],"text":"Comparison of hydroxychloroquine vs. ascorbic acid in contacts of COVID-19 patients. Double-blind RCT (NCT04328961, not yet recruiting). Primary endpoint: laboratory-confirmed COVID-19 (follow-up 14 days)."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T197","span":{"begin":85,"end":136},"obj":"Sentence"},{"id":"T198","span":{"begin":137,"end":205},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Comparison of hydroxychloroquine vs. ascorbic acid in contacts of COVID-19 patients. Double-blind RCT (NCT04328961, not yet recruiting). Primary endpoint: laboratory-confirmed COVID-19 (follow-up 14 days)."}